Deutsche Bank AG Makes New $6.02 Million Investment in Privia Health Group, Inc. $PRVA

Key Points

• Deutsche Bank invested approximately $6.02 million in Privia Health Group during the second quarter, acquiring 234,049 shares and holding about 0.19% of the company. Institutional investors collectively own 94.48% of PRVA.
• Privia Health reported quarterly earnings of $0.19 per share, beating the $0.07 consensus estimate, while revenue rose 21.4% year over year to $632.63 million. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $31.00.
• Company insiders sold 327,886 shares worth approximately $8.63 million over the past 90 days, including sizable sales by the CFO and a director under pre-arranged Rule 10b5-1 trading plans.

Deutsche Bank AG purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 234,049 shares of the company's stock, valued at approximately $6,022,000. Deutsche Bank AG owned approximately 0.19% of Privia Health Group at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in PRVA. Bayban purchased a new position in Privia Health Group during the fourth quarter worth about $26,000. Hantz Financial Services Inc. boosted its position in shares of Privia Health Group by 456.2% during the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company's stock valued at $27,000 after acquiring an additional 926 shares during the last quarter. Global Retirement Partners LLC boosted its position in shares of Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock valued at $38,000 after acquiring an additional 1,351 shares during the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of Privia Health Group during the second quarter worth about $69,000. Finally, Canada Pension Plan Investment Board increased its position in shares of Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Price Performance

Shares of PRVA stock opened at $21.02 on Tuesday. The stock has a market capitalization of $2.68 billion, a PE ratio of 100.10, a P/E/G ratio of 1.67 and a beta of 0.85. Privia Health Group, Inc. has a 1-year low of $19.53 and a 1-year high of $28.82. The business has a 50-day moving average of $24.54 and a 200 day moving average of $23.22.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.12. The firm had revenue of $632.63 million during the quarter, compared to the consensus estimate of $597.33 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%.The business's revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.24 earnings per share. Analysts anticipate that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Analyst Upgrades and Downgrades

PRVA has been the subject of several research analyst reports. Canaccord Genuity Group set a $32.00 target price on shares of Privia Health Group in a research report on Friday, August 7th. Weiss Ratings raised shares of Privia Health Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, July 2nd. Citigroup restated a "buy" rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 5th. Finally, Barclays cut their target price on shares of Privia Health Group from $25.00 to $24.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 26th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $31.00.

Insider Buying and Selling at Privia Health Group

In related news, CFO David Mountcastle sold 24,734 shares of the company's stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the completion of the sale, the chief financial officer directly owned 186,728 shares in the company, valued at $5,135,020. This represents a 11.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 88,110 shares of the company's stock in a transaction on Friday, June 26th. The shares were sold at an average price of $25.33, for a total transaction of $2,231,826.30. Following the sale, the director owned 76,651 shares of the company's stock, valued at $1,941,569.83. This represents a 53.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 327,886 shares of company stock worth $8,628,256. 5.70% of the stock is owned by insiders.

Privia Health Group Company Profile

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source